Contractile and relaxant actions of prostaglandins on guinea-pig isolated trachea.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMC 2044219)

Published in Br J Pharmacol on March 01, 1980

Authors

R A Coleman, I Kennedy

Articles citing this

The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist. Br J Pharmacol (1989) 2.09

Antagonism of Ca2+ and other actions of verapamil in guinea-pig isolated trachealis. Br J Pharmacol (1984) 1.59

The action of prostanoid receptor agonists and antagonists on smooth muscle and platelets. Br J Pharmacol (1988) 1.16

Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig. Br J Pharmacol (1990) 1.15

Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins. Br J Pharmacol (2001) 1.01

Role of PGE(2) in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea. Br J Pharmacol (2001) 0.95

Prostaglandins and the control of airways responses to histamine in normal and asthmatic subjects. Thorax (1983) 0.94

Dual effect of prostaglandin E2 on normal airways smooth muscle in vivo. Thorax (1982) 0.90

Evidence for prejunctional inhibitory muscarinic receptors on sympathetic nerves innervating guinea-pig trachealis muscle. Br J Pharmacol (1991) 0.88

Interactions between response to inhaled prostaglandin E2 and chronic beta-adrenergic agonist treatment. Thorax (1982) 0.81

The relaxant effect induced by Allium sativum L. bulb aqueous extract on rat isolated trachea. Pharmacogn Mag (2011) 0.78

PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors. Br J Pharmacol (2013) 0.77

Sir David Jack: an extraordinary drug discoverer and developer. Br J Clin Pharmacol (2013) 0.75

Articles cited by this

Evidence for nonadrenergic inhibitory nerves in the guinea pig trachealis muscle. Am J Physiol (1973) 2.91

New class of selective stimulants of beta-adrenergic receptors. Nature (1968) 2.72

Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220. Br J Pharmacol (1974) 2.19

Effect on airways resistance of prostaglandin E1 given by aerosol to healthy and asthmatic volunteers. Br Med J (1969) 2.01

Prostaglandin endoperoxides IV. Effects on smooth muscle. Life Sci (1975) 1.89

Potent bronchoconstrictor activity of 15-keto prostaglandin F2alpha. Nature (1974) 1.84

Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins (1977) 1.82

Effect of prostaglandins F2 alpha and E2 on airway conductance in healthy subjects and asthmatic patients. Am Rev Respir Dis (1975) 1.66

Antagonistic Action of Aerosols of Prostaglandins F(2)alpha and E(2) on Bronchial Muscle Tone in Man. Br Med J (1972) 1.28

Effects of inhaled prostaglandins E1, E2, and F2alpha on the airway resistance of healthy and asthmatic man. Clin Sci Mol Med (1975) 1.24

Reduction of antigen-induced contraction of sensitized human bronchus in vitro by indomethacin. Br J Pharmacol (1975) 1.12

The effects of arachidonic acid, indomethacin and SC-19220 on guinea-pig tracheal muscle tone. Eur J Pharmacol (1975) 1.09

The effects of some natural prostaglandins on isolated human circular bronchial muscle. Prostaglandins (1975) 1.06

The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S). Prostaglandins (1977) 0.96

Aspects of prostaglandin function in the lung (first of two parts). N Engl J Med (1977) 0.96

Comparison of the effects of prostaglandin analogues on rabbit platelets, rabbit isolated vascular tissues and rabbit skin microvasculature [proceedings]. Br J Pharmacol (1978) 0.85

Prostaglandins as bronchodilators. N Y State J Med (1975) 0.84

The effects of intravenous infusion of graded doses of prostaglandins F 2 and E 2 on lung resistance in patients undergoing termination of pregnancy. Clin Sci (1973) 0.83

Prostaglandins and asthma. Br J Clin Pharmacol (1975) 0.81

The effect of prostaglandin F2beta on expiratory flow rates. Prostaglandins (1975) 0.81

Articles by these authors

The case for allowing kidney sales. International Forum for Transplant Ethics. Lancet (1998) 5.25

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol (1972) 4.53

Should organs from patients in permanent vegetative state be used for transplantation? International Forum for Transplant Ethics. Lancet (1997) 4.04

Glycogen storage disease in adults. Ann Intern Med (1994) 3.58

ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--a possible sensory mechanism? J Physiol (1997) 3.43

Enzymes of glycerolipid synthesis in eukaryotes. Annu Rev Biochem (1980) 3.06

Immunocytochemical localization of phytochrome. Proc Natl Acad Sci U S A (1971) 2.81

Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol (1981) 2.79

Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins (1982) 2.73

A new preparation of the isolated intact trachea of the guinea-pig. J Pharm Pharmacol (1970) 2.58

AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target. Biochem J (1999) 2.46

Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol (1991) 2.41

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group. J Clin Oncol (1999) 2.29

An immunochemical characterization of the phytochrome destruction reaction. Biochim Biophys Acta (1974) 2.20

Analysis of amino acid motifs diagnostic for the sn-glycerol-3-phosphate acyltransferase reaction. Biochemistry (1999) 2.04

Reversible redistribution of phytochrome within the cell upon conversion to its physiologically active form. Proc Natl Acad Sci U S A (1975) 2.01

A non-adrenergic inhibitory nervous pathway in guinea-pig trachea. Br J Pharmacol (1974) 1.97

The inducement of tone and its inhibition in isolated tracheal muscle. J Pharm Pharmacol (1971) 1.95

Selective changes in microsomal enzymes of triacylglycerol phosphatidylcholine, and phosphatidylethanolamine biosynthesis during differentiation of 3T3-L1 preadipocytes. J Biol Chem (1978) 1.86

Effects of some purine derivatives on the guinea-pig trachea and their interaction with drugs that block adenosine uptake. Br J Pharmacol (1976) 1.77

Genome of infectious bronchitis virus. J Virol (1977) 1.74

Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. Br J Pharmacol (1975) 1.72

Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem (2001) 1.64

Expression and characterization of recombinant rat Acyl-CoA synthetases 1, 4, and 5. Selective inhibition by triacsin C and thiazolidinediones. J Biol Chem (2001) 1.64

AH23848: a thromboxane receptor-blocking drug that can clarify the pathophysiologic role of thromboxane A2. Circulation (1985) 1.63

Leptin directly alters lipid partitioning in skeletal muscle. Diabetes (1997) 1.57

Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem (1996) 1.48

Electron microscopic localization of phytochrome in plants using an indirect antibody-labeling method. J Histochem Cytochem (1974) 1.47

Renal disease in type I glycogen storage disease. N Engl J Med (1988) 1.45

Inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet (1991) 1.40

"Selectivity" and "specificity": what do they mean? Gen Pharmacol (1993) 1.40

Nodes in the neck. S Afr Med J (1996) 1.39

Foreign bodies and balloon catheters. Trop Doct (1996) 1.39

Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA. Biochem J (1997) 1.39

Lipid topogenesis. J Lipid Res (1981) 1.36

Functional characterization of three adenosine receptor types. Br J Pharmacol (1993) 1.35

New evidence with selective agonists and antagonists for the subclassification of PGE2-sensitive (EP) receptors. Adv Prostaglandin Thromboxane Leukot Res (1987) 1.35

A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig. J Pharm Pharmacol (1970) 1.34

The donation and transplantation of kidneys: should the law be changed? J Med Ethics (1979) 1.32

U-46619, a selective thromboxane A2-like agonist? [proceedings]. Br J Pharmacol (1980) 1.28

Neutral lipid storage disease with fatty liver and cholestasis. J Pediatr Gastroenterol Nutr (1997) 1.27

Mitochondrial glycerol phosphate acyltransferase directs the incorporation of exogenous fatty acids into triacylglycerol. J Biol Chem (2001) 1.26

Characterisation of the prostanoid receptors mediating contraction of guinea-pig isolated trachea. Prostaglandins (1985) 1.26

Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr (1990) 1.22

Neutral lipid storage disease: a genetic disorder with abnormalities in the regulation of phospholipid metabolism. J Lipid Res (1998) 1.22

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer. J Clin Oncol (1999) 1.21

Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils. Br J Pharmacol (1995) 1.19

Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem (1996) 1.18

Regulation of mitochondrial sn-glycerol-3-phosphate acyltransferase activity: response to feeding status is unique in various rat tissues and is discordant with protein expression. Arch Biochem Biophys (2001) 1.14

Dynamic interplay of TFIIA, TBP and TATA DNA. J Mol Biol (1997) 1.13

Immunolocalization of the secretory isoform of Na-K-Cl cotransporter in rat renal intercalated cells. J Am Soc Nephrol (1996) 1.13

The pharmacology of salmeterol. Life Sci (1993) 1.13

Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol. Br J Pharmacol (1993) 1.12

Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction. Drug Metab Dispos (2000) 1.11

Diacylglycerol acyltransferase and monoacylglycerol acyltransferase from liver and intestine. Methods Enzymol (1992) 1.11

Independent effects of patch size and structural complexity on diversity of benthic macroinvertebrates. Ecology (2010) 1.10

A critique of the Law Commission report on injuries to unborn children and the proposed Congenital Disabilities (Civil Liability) Bill. J Med Ethics (1975) 1.08

Studies on the characterization of prostanoid receptors. Adv Prostaglandin Thromboxane Leukot Res (1983) 1.07

Rat sn-glycerol-3-phosphate acyltransferase: molecular cloning and characterization of the cDNA and expressed protein. Biochim Biophys Acta (1999) 1.06

Selective changes in microsomal enzymes of triacylglycerol and phosphatidylcholine synthesis in fetal and postnatal rat liver. Induction of microsomal sn-glycerol 3-phosphate and dihydroxyacetonephosphate acyltransferase activities. J Biol Chem (1983) 1.05

Myopathy and growth failure in debrancher enzyme deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr (1984) 1.03

Mitochondrial glycerol phosphate acyltransferase contains two transmembrane domains with the active site in the N-terminal domain facing the cytosol. J Biol Chem (2001) 1.03

Characterization of dilator prostanoid receptors in the fetal rabbit ductus arteriosus. J Pharmacol Exp Ther (1994) 1.02

The cat isolated trachea, a useful preparation for the study of the smooth muscle relaxant action of prostaglandins [proceedings]. Br J Pharmacol (1979) 1.01

Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve. Br J Pharmacol (1993) 1.01

Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification. Br J Pharmacol (1994) 1.01

The effects of epithelium removal on the actions of cholinomimetic drugs in opened segments and perfused tubular preparations of guinea-pig trachea. Br J Pharmacol (1990) 1.00

Improvement of muscle function in acid maltase deficiency by high-protein therapy. Neurology (1983) 1.00

Uptake and scanning of the salivary glands in man using pertechnetate-99m-Tc. Clin Sci (1967) 1.00

Selective retention of essential fatty acids: the role of hepatic monoacylglycerol acyltransferase. Am J Physiol (1993) 0.99

Neutral lipid storage disease: a possible functional defect in phospholipid- linked triacylglycerol metabolism. Biochim Biophys Acta (1991) 0.99

Influence of abstinence and ejaculation-to-analysis delay on semen analysis parameters of suspected infertile men. Arch Androl (1982) 0.99

Characterization of the prostanoid receptors mediating constriction and relaxation of human isolated uterine artery. Br J Pharmacol (1995) 0.99

Purine antagonists in the identification of adenosine-receptors in guinea-pig trachea and the role of purines in non-adrenergic inhibitory neurotransmission. Br J Pharmacol (1980) 0.99

Monoacylglycerol acyltransferase. Evidence that the activities from rat intestine and suckling liver are tissue-specific isoenzymes. J Biol Chem (1986) 0.99

Effects of beta-adrenoceptor agonists in human bronchial smooth muscle. Br J Pharmacol (1993) 0.99

The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate. Br J Pharmacol (1994) 0.98

Hepatic monoacylglycerol acyltransferase. Characterization of an activity associated with the suckling period in rats. J Biol Chem (1984) 0.98

An experimental model to investigate the dynamics of wound contraction. Br J Plast Surg (1995) 0.98

Rat renal arcade segment expresses vasopressin-regulated water channel and vasopressin V2 receptor. J Clin Invest (1996) 0.98

Annual patterns of human sperm production and semen quality. Arch Androl (1983) 0.96

Solubilization and partial purification of neonatally expressed rat hepatic microsomal monoacylglycerol acyltransferase. Arch Biochem Biophys (1993) 0.96

Leptin opposes insulin's effects on fatty acid partitioning in muscles isolated from obese ob/ob mice. Am J Physiol (1999) 0.95

Comparison of the potencies of some prostaglandins as vasodilators in three vascular beds of the anaesthetised dog. Eur J Pharmacol (1982) 0.95

Erythromycin, lincosamides, peptidyl-tRNA dissociation, and ribosome editing. Mol Gen Genet (1994) 0.95

Rethinking medical ethics. J R Coll Surg Edinb (1982) 0.94

5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol (2002) 0.93

Spasmogen action in guinea-pig isolated trachealis: involvement of membrane K+-channels and the consequences of K+-channel blockade. Br J Pharmacol (1988) 0.93

New insights on P2X purinoceptors. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.92

Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors. Prostaglandins (1992) 0.92

Individual variation in gonadotrophin and steroid concentrations and in the lengths of the follicular and luteal phases in women with regular menstrual cycles. Clin Reprod Fertil (1983) 0.92

Evoked potentials in severe head injury--analysis and relation to outcome. J Neurol Neurosurg Psychiatry (1981) 0.92

Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques. Invest Ophthalmol Vis Sci (2000) 0.91